• Mashup Score: 18

    Heart failure affects approximately six million Americans and is the most common diagnosis for acute hospitalization in patients over 65 years. Over the next decade, we will see a dramatic increase in the number of patients in the community with advanced heart failure who can benefit from advanced therapies for complex cardiac disease. Academic medical centers, such as UCLA, have an opportunity to integrate treatment advances into a comprehensive patient-centered heart failure management program. UCLA Health wants to enhance the role of the primary care physician and primary cardiologist as the central provider for continuity of care for these complex heart failure patients. The 11th Annual UCLA Heart Failure Symposium 2023 will: 1. Discuss general heart failure treatment options including short and long term mechanical circulatory support therapy, heart transplantation, pulmonary hypertension management, high risk percutaneous and structural interventions, and complex congenital heart

    Tweet Tweets with this article
    • Only two weeks to register for the @UCLAHealth in person & virtual State of the Art Advanced Heart Failure Symposium sponsored by @HFSA ! https://t.co/3dAZ50RhpS https://t.co/IrC7YTSjkM https://t.co/Mqc4uDFr30

  • Mashup Score: 2

    Heart failure affects approximately six million Americans and is the most common diagnosis for acute hospitalization in patients over 65 years. Over the next decade, we will see a dramatic increase in the number of patients in the community with advanced heart failure who can benefit from advanced therapies for complex cardiac disease. Academic medical centers, such as UCLA, have an opportunity to integrate treatment advances into a comprehensive patient-centered heart failure management program. UCLA Health wants to enhance the role of the primary care physician and primary cardiologist as the central provider for continuity of care for these complex heart failure patients. The 11th Annual UCLA Heart Failure Symposium 2023 will: 1. Discuss general heart failure treatment options including short and long term mechanical circulatory support therapy, heart transplantation, pulmonary hypertension management, high risk percutaneous and structural interventions, and complex congenital heart

    Tweet Tweets with this article
    • Join us (in-person & virtual) for our CME accredited @UCLAHealth Heart Failure & Advanced Cardiovascular Therapies Symposium, Sept 23 in beautiful Marina Del Rey for latest Medical, Interventional & Surgical State of the Art Therapies. @HFSA @CaliforniaACC https://t.co/3dAZ50RhpS https://t.co/EEWvw7srGz

  • Mashup Score: 7

    COURSE CHAIR Ali Nsair, MD Medical Director, Heart Transplantation and Mechanical Circulatory Support Device Services Heart Failure Interventional Cardiology Broad Stem Cell Research Center GUEST SPEAKER Kareem Abdul-Jabbar Former Los Angeles Laker NBA Hall of Famer UCLA COURSE FACULTY AND PANEL PARTICIPANTS Jamil Aboulhosn, MD, FACC Professor…

    Tweet Tweets with this article
    • Please join us for in person and virtual @HFSA endorsed symposium September 10 @RitzCarlton in Marina del Rey for State-of-the-Art CME symposium on Medical, Interventional & Surgical therapies for #AHF #OHT #MCS #ECMO & hear from our experts! Register here https://t.co/DYOvrzYRGP https://t.co/9jHJXuBZVA

  • Mashup Score: 5

    Course Information UCLA Heart Failure Symposium 2022: Symposium on State-of-the-Art Updates and Therapies for Advanced Heart Failure Live In-Person & Live Virtual Learning The Ritz-Carlton, Marina del Rey Marina Del Rey, California September 10, 2022 Download: [ PDF ] Course Description More…

    Tweet Tweets with this article
    • Our #CME symposium on advanced heart failure, interventional, structural and surgical therapies offers a hybrid VIRTUAL & In-Person attendace option for those who can't make it person. Check out the registration for in person and virtual attendance. https://t.co/DYOvrAgsyn https://t.co/5owu6dDQRj

  • Mashup Score: 0

    With the increasing number of COVID-19 cases from the Omicron variant and in preparation for an anticipated surge in patients, CDC updated their guidance for HCP isolation and quarantine to reflect what is currently known about infection and exposure in the context of vaccination and booster doses.  Additionally, CDC updated their guidance for contingency and crisis management to mitigate the…

    Tweet Tweets with this article
    • As a Dr who cares for #HF & ❤️ #Transplant pts, worry that #CDPH recs expose immunecompromised pts to #COVID19 +ve #HCWs. #Transplant pts are NOT as protected by vaccines & thoracic Tx pts fair poorly w #COVID19. Must do better. @HFSA @ISHLT @CaliforniaACC https://t.co/1UfNjRUXVt https://t.co/HEH7cNhegf

  • Mashup Score: 7

    COURSE CHAIR Ali Nsair, MD Medical Director, Heart Transplantation and Mechanical Circulatory Support Device Services Heart Failure Interventional Cardiology Broad Stem Cell Research CenterUCLA COURSE FACULTY AND PANEL PARTICIPANTS Jamil Aboulhosn, MD, FACC Professor of Clinical Medicine and Pediatrics Director, Ahmanson/UCLA Adult Congenital Heart Disease…

    Tweet Tweets with this article
    • Come join our renowned #UCLA experts discuss state of the art cardiac therapies - #GDMT #CHIP #TAVR #MitraClip #MCS #ECMO #OHT #VAD for an in-person & Virtual Hybrid CME Program Sept18/21 @ Ritz-Carlton, Marina Del Rey. @gcfmd @UCLAHealth @HFSA @ACCinTouch https://t.co/tmnfHD0ofm https://t.co/NMunGe2Ypp